Company Actelion CBOE EUROPE EQUITIES
Equities
ATLN
CH0010532478
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CHF | - |
|
2017 | Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake | RE |
2017 | Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 107,329,410 | 2,009,425 ( 1.872 %) | 4,654,225 ( 4.336 %) | 1.872 % |
Company contact information
Actelion Ltd.
Gewerbestrasse 16
4123, Allschwil
+
![address Actelion(ATLN)](https://cdn.zonebourse.com/static/address/16414486.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |
- Stock Market
- Equities
- ATLN Stock
- ATLN Stock
- Company Actelion